Form 4: Monopar Therapeutics CFO Kim R. Tsuchimoto Reports Stock Transactions

Sentiment:

SEC Form 4 Filing


Kim R. Tsuchimoto, CFO of Monopar Therapeutics, reports the acquisition and disposal of common stock related to the vesting of restricted stock units.

Summary

  • On June 30, 2024, Kim R. Tsuchimoto, the Chief Financial Officer of Monopar Therapeutics, reported transactions involving the company's common stock.
  • These transactions involved the vesting and settlement of restricted stock units (RSUs).
  • Specifically, 9,957 shares were acquired upon the vesting of RSUs.
  • Additionally, 2,998 shares were withheld by the issuer to cover withholding taxes related to the vesting of these RSUs.
  • Following these transactions, Tsuchimoto directly owns 57,429 shares of Monopar Therapeutics.
  • The price per share for the tax withholding was $0.731.

Sentiment

Score: 5

Explanation: The sentiment is neutral as the filing simply reports routine stock transactions related to RSU vesting. It doesn't inherently indicate positive or negative performance.

Positives

  • The vesting of RSUs indicates that performance milestones or time-based conditions have been met.

Industry Context

Form 4 filings are standard practice and provide transparency into the transactions of company insiders, allowing investors to track ownership changes and potential alignment of interests.

Stakeholder Impact

  • Shareholders can monitor insider transactions to gain insights into management's perspective on the company's stock.

Key Dates

DateDescription
01/26/2021Grant date of 19,536 restricted stock units, vesting quarterly until December 31, 2024.
02/02/2022Grant date of 61,532 restricted stock units, vesting quarterly until December 31, 2025.
02/01/2023Grant date of 78,234 restricted stock units, vesting quarterly until December 31, 2026.
06/30/2024Date of reported transactions: acquisition of 9,957 shares via RSU vesting and disposal of 2,998 shares for tax withholding.
07/02/2024Date of filing.
12/31/2024RSUs granted on January 26, 2021 fully vested.
12/31/2025RSUs granted on February 2, 2022 fully vested.
12/31/2026RSUs granted on February 1, 2023 fully vested.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.